Lipids and Lipoproteins in AtherosclerosisView this Special Issue
Research Article | Open Access
Human Plasma Very Low-Density Lipoproteins Are Stabilized by Electrostatic Interactions and Destabilized by Acidic pH
Very low-density lipoproteins (VLDL) are precursors of low-density lipoproteins (LDL, or “bad cholesterol”). Factors affecting structural integrity of VLDL are important for their metabolism. To assess the role of electrostatic interactions in VLDL stability, we determined how solvent ionic conditions affect the heat-induced VLDL remodeling. This remodeling involves VLDL fusion, rupture, and fission of apolipoprotein E-containing high-density lipoprotein-(HDL-) like particles similar to those formed during VLDL-to-LDL maturation. Circular dichroism and turbidity show that increasing sodium salt concentration in millimolar range reduces VLDL stability and its enthalpic component. Consequently, favorable electrostatic interactions stabilize VLDL. Reduction in pH from 7.4 to 6.0 reduces VLDL stability, with further destabilization detected at pH < 6, which probably results from titration of the N-terminal α-amino groups and free fatty acids. This destabilization is expected to facilitate endosomal degradation of VLDL, promote their coalescence into lipid droplets in atherosclerotic plaques, and affect their potential use as drug carriers.
Very low-density lipoproteins (VLDL) are the major plasma carriers of fat (triacylglycerides, TG) and direct metabolic precursors of low-density lipoproteins (LDL, or “bad cholesterol”). Elevated plasma levels of TG are a hallmark of the metabolic syndrome and a risk factor for atherosclerosis [1–6]. Human plasma VLDL are heterogeneous particles (d~35–100 nm) that contain a large apolar core comprised mainly of TG and cholesterol esters and polar surface comprised of apolipoproteins (apos) and a phospholipid monolayer (Figure 1). Each VLDL particle contains one copy of the nonexchangeable (water-insoluble) apoB (550 kDa) that comprises nearly one half of its total protein content ; the other half is comprised of multiple copies of the exchangeable proteins, apoE (32 kDa) and apoCs (6–9 kD). During VLDL metabolism (recently reviewed in ), core TG are enzymatically hydrolyzed to produce free fatty acids that are used as an energy source by various tissues. Upon TG hydrolysis, the lipoprotein core shrinks and the excess surface material fissions in the form of small apoE-containing particles that join the plasma pool of high-density lipoproteins (HDL, or “good cholesterol”, d~10 nm) [7–9] (Figure 1). Eventually, VLDL are converted to LDL (d~22 nm) that contain one copy of apoB comprising >90% of their total protein content.
Similar to LDL, VLDL uptake by the cells involves receptor-mediated whole-particle endocytosis. In contrast to LDL that are degraded in the lysosomes, VLDL degradation is a complex process that starts in early endosomes with dissociation of apoE together with a fraction of phospholipids; apoE eventually gets recycled, while the remaining apoB-containing particle undergoes lysosomal degradation [10–12]. Such receptor-mediated uptake of the apoB-containing lipoproteins downregulates cell cholesterol biosynthesis and is antiatherogenic. Alternatively, LDL and VLDL can bind to the arterial wall proteoglycans where they get retained and modified by hydrolytic and oxidative enzymes in the subendothelial space [13–15]. Such retention of the apoB-containing lipoproteins is believed to be the key initiating step in atherogenesis ( and references therein). It leads to a cascade of proatherogenic responses, including lipoprotein fusion into lipid droplets that are found in atherosclerotic plaques [17–19]. Such droplets are readily taken up by macrophages, which promotes formation of foam cells and progression of atherosclerosis ( and references therein). Our goal is to provide the energetic and structural basis for understanding key determinants for structural integrity of VLDL assembly and its remodeling into large and small particles and lipid droplets.
Because of the experimental difficulties in analyzing structural stability of large heterogeneous lipid-loaded particles, studies of VLDL stability have been limited to our own work performed in 10 mM Na phosphate, pH 7.6 . The results showed that thermal denaturation of VLDL is a complex kinetically controlled transition with two kinetic phases reflecting distinct morphologic transformations. The first phase involves VLDL fusion and dissociation of small spherical apoE-containing particles (d = 7–15 nm) whose size, density, and biochemical composition closely resemble a subclass of plasma HDL formed during metabolic remodeling of VLDL (Figure 1). The second phase involves complete lipoprotein disintegration and coalescence into lipid droplets whose size and morphology resemble lipid droplets found in atherosclerotioc plaques . Hence, thermal denaturation of VLDL mimics key aspects of their metabolic remodeling in vivo and provides a useful model for elucidating the energetic and structural basis for this remodeling .
As neutral lipids comprise over 80% of the total VLDL mass, hydrophobic interactions are likely to dominate VLDL stability. However, electrostatic interactions are also likely to contribute, as suggested by the presence of small amounts of anionic lipids in VLDL, mainly free fatty acids and phosphatidylinositol, as well as by the sequence properties of the class-A amphipathic α-helices that form the major lipid surface-binding motif in the exchangeable apolipoproteins and are also found in the nonexchangeable apoB on VLDL . Characteristic radial distribution and high content of charged residues in class-A helices (30–50% as compared to ~15% in typical globular proteins) facilitate formation of multiple salt bridges. These and other electrostatic interactions, which are amplified by the low dielectric at the lipid surface (ε~10 as compared to 80 in water), have been predicted  and observed to significantly affect the stability of model and plasma HDL [23–25]. Furthermore, charge-charge interactions are central to many functional interactions of lipoproteins with their metabolic partners, including VLDL interactions with lipophilic plasma enzymes, cell receptors, and arterial wall proteoglycans ([26–29] and references therein). Here, we explore the role of electrostatic interactions in structural stability and remodeling of human VLDL.
This paper reports the effects of solvent ionic conditions (pH 5.7–8.2, 1–150 mM Na salt) on thermal denaturation of human VLDL. The results reveal that (i) electrostatics interactions provide a large favorable enthalpic contribution to VLDL stability and (ii) reduction in pH from mildly basic to mildly acidic destabilizes VLDL and accelerates their remodeling. We propose a plausible explanation for these effects and postulate that reduction in VLDL stability upon reduction in pH, which occurs upon receptor-mediated VLDL transfer from plasma (pH 7.4) to early endosomes (pH~6) [10–12] or upon VLDL retention in the arterial wall and macrophage-induced acidification ( and references therein), may have important implications for VLDL metabolism.
2. Materials and Methods
2.1. VLDL Isolation and Characterization
Single-donor human VLDL were isolated as described  from EDTA-treated plasma of six healthy volunteer donors according to regulations of the Institutional Review Board. Briefly, VLDL were isolated by density gradient centrifugation in the density range 0.94–1.006 g/mL . Total VLDL migrated as a single band on the agarose gel (Figure 2). Total human VLDL are comprised of two main subclasses, VLDL1 (d = 60–100 nm) and VLDL2 (d = 35–60 nm), containing one molecule of apoB per particle and numerous copies of apoE and apoCs (greater in larger particles). To improve sample homogeneity and to minimize light scattering in spectroscopic experiments, smaller VLDL2 particles were isolated by an additional round of centrifugation at 40,000 rpm for 30 min as described  and were used for further studies. The VLDL solution containing about 2 mg/mL protein was dialyzed against standard buffer (10 mM Na phosphate, 0.25 mM EDTA, 0.02% NaN3, pH 7.6). This stock solution was stored in the dark at 4°C and was used in 2-3 weeks during which we detected no change in VLDL charge by agarose gel, no protein degradation by SDS PAGE, and no changes in the protein conformation or particle stability by CD spectroscopy. Even though plasma lipoproteins isolated from different batches showed small batch-to-batch variations in stability reflecting small donor-specific variations in lipoprotein composition, the overall tends reported in this paper were similar for all VLDL batches explored. Therefore, lipoprotein heterogeneity did not affect the key conclusions of this study.
VLDL subjected to various thermal treatments were visualized at 25°C by negative staining electron microscopy (EM) using a CM12 transmission electron microscope (Philips Electron Optics) as described .
2.2. Solvent Conditions
Solvent ionic conditions explored in our thermal denaturation studies ranged from 1 to 150 mM Na salt, pH 5.7–8.2. At mildly acidic pH in ≥100 mM salt, VLDL were destabilized to such an extent that their decomposition and lipid phase separation occurred at ambient temperatures; this limited our experimental analysis of the pH effects to low-salt conditions. Similarly, at pH < 6.0 VLDL destabilization was observed at ambient temperatures in any salt concentration (including 150 mM NaCl), preventing quantitative studies of VLDL stability at these low pH. Hence, the results reported here are limited to pH ≥ 6.0. For pH studies, VLDL stock solution was dialyzed against 10 mM Na phosphate buffer varying in pH from 6.0 to 8.2. For studies of the ionic strength effects, buffered solution of NaCl, Na2SO4 or Na phosphate at pH 7.6 was added to VLDL stock solution to a final salt concentration ranging from 1 to 150 mM.
To test the effects of salts other than Na phosphate and to avoid the effects of buffer saline, we attempted to use dilute TRIS buffer at pH 7.7. The melting data progressively shifted to lower temperatures upon increasing TRIS concentrations in low millimolar range, indicating VLDL destabilization (see Figure S1 in Supplementary Materials available online at doi: 10.1155/2011/493720). Addition of salt caused further destabilization (Figure S1), leading to rapid lipid phase separation upon heating which precluded accurate analysis of the VLDL stability. Similar destabilizing effect of TRIS at low mM concentrations was observed in LDL, HDL, and in apoA-I isolated from HDL (unpublished data), suggesting strongly that TRIS interacts unfavorably with this and other apolipoproteins. Therefore, in our structural stability studies we used 10 mM Na phosphate buffer rather than TRIS.
2.3. Circular Dichroism (CD) and Turbidity
CD and turbidity data were recorded using an AVIV spectropolarimeter with thermoelectric temperature control as described . Briefly, the CD data were recorded using VLDL solutions of about 0.1 to 0.15 mg/mL protein concentrations in far-UV (190–250 nm) or about 0.5 mg/mL protein in near-UV/vis (250–500 nm). Since earlier we showed that changes in VLDL concentration significantly affect the amplitude of the heat-induced structural transition but not its apparent melting temperature Tm  (which implies that particle collision does not provide a rate-limiting step in VLDL remodeling), the key conclusions of our study do not depend on the VLDL concentrations used. Far-UV CD spectra were normalized to protein concentration (based on the total protein concentration in mg/mL and assuming an average molecular weight per residue of 113 Da) and expressed as molar residue ellipticity, [Θ]. Quantitative secondary structural analysis was not carried out because of distortions in the CD spectra of large particles. Heat-induced changes in turbidity were monitored by dynode voltage V in CD experiments as described [20, 32], either at 220 nm or at 230 nm, together with the CD data recorded at the same wavelength (220 nm for secondary structure unfolding and 320 nm for repacking of apolar lipids, described below). Turbidity data recorded at either wavelength were qualitatively similar.
In the melting experiments, CD and turbidity data, Θ(T) and V(T), were recorded simultaneously at 220 or 320 nm during sample heating and cooling from 25 to 98°C at a constant rate of 11°C/h. The apparent transition temperatures Tm were determined from the peak positions in the first derivative of the heating data, dV(T)/dT or dΘ(T)/dT; the accuracy of this determination was 1°C. Turbidity was used to monitor heat-induced increase in the particle size upon VLDL fusion and rupture, and CD was used to monitor VLDL rupture and release of apolar core lipids that coalesce into large lipid droplets. Earlier we showed that such droplet formation, which was detected upon rupture of all core-containing human lipoproteins, induces a large negative CD peak centered at 320 nm . The amplitude of this peak increased with increasing the lipoprotein size, HDL < LDL < VLDL, and the size of the resulting droplets. This induced CD apparently results from the apolar lipids such as TG, cholesterol esters, and carotenoids, upon their escape from the lipoprotein core and repacking in lipid droplets. In VLDL, this negative CD peak was so large that it extended to far-UV and dominated the heat-induced changes in Θ220(T) . Therefore, in contrast to conventional use of far-UV CD for monitoring protein unfolding, we use Θ220(T) to monitor lipid repacking upon VLDL rupture and formation of lipid droplets .
In kinetic temperature-jump (T-jump) experiments, VLDL denaturation was triggered at by rapid heating from 25°C to a higher constant temperature (70–95°C). The time course of VLDL fusion and rupture was monitored by turbidity (dynode voltage), V(t). Data analysis was carried out by using an Arrhenius model. Briefly, the kinetic data recorded at each temperature were approximated with a multiexponential decay function: Here, Ai is the amplitude, and ki is the temperature-dependent rate constant of the ith kinetic phase. Since VLDL denaturation is irreversible, the reaction rate equals the denaturation rate. The rate constants ki(T) were determined by fitting the V(t) data with the multi-exponentials, and the Arrhenius activation energy (enthalpy) for each kinetic phase was determined from the slope of the Arrhenius plot, versus 1/T. Changes in the Gibbs free energy of stability, , were assessed from the shifts in these plots. All experiments in this work were repeated 3–6 times to ensure reproducibility.
3.1. Effects of pH
VLDL structure and stability were analyzed in 10 mM Na phosphate buffer varying in pH from 6.0 to 8.2. The results showed that such variations produced no detectable changes in the secondary structural content of VLDL proteins assessed by far-UV CD (Figure 2(a)), in the aromatic packing in these proteins assessed by near-UV CD (data not shown), or in the net charge on VLDL assessed by agarose gel electrophoresis (Figure 2(b)). Also, the size and morphology of intact VLDL remained invariant in this pH range, as evident from the electron micrographs recorded of VLDL under acidic (Figure 3(a)) or basic conditions and ambient temperatures . Furthermore, EM data showed that the heat-induced remodeling of VLDL proceeds via similar stages at various solvent ionic conditions explored, such as pH 6.2 and pH 7.6 shown in Figure 3 and in , respectively. This remodeling involves VLDL fusion, rupture and fission of small apoE-containing HDL-like particles described before . The results of the current work revealed that the apparent temperatures of these structural transitions are pH dependent. To test this pH dependence, VLDL samples (0.1 mg/mL protein in 10 mM Na phosphate buffer at pH 6.0–8.2) were heated at a constant rate of 11°C/h, and CD and turbidity were measured simultaneously at 320 nm to monitor VLDL rupture and lipid repacking upon coalescence into droplets (by CD) and increase in the particle size due to fusion and lipid droplet formation (by turbidity). The results revealed that the reduction in pH from pH 8.2 to 6.0 led to a low-temperature shift in the CD and turbidity heating data by more than −10°C (Figures 4(a) and 4(b)), indicating a large reduction in VLDL stability at acidic pH.
This notion was further tested in kinetic T-jump experiments. VLDL denaturation was triggered by a rapid heating from 25°C to higher constant temperatures, and its time course was monitored by turbidity at 220 nm, V220(t). Figure 4(c) illustrates a subset of data recorded at pH 6.0–7.8 in T-jumps to 80°C. These and other kinetic data recorded in the range of pH 6.0–8.2 clearly show that reduction in pH progressively accelerates VLDL denaturation and, hence, is destabilizing.
Earlier, we carried out Arrhenius analysis of the T-jump data recorded of VLDL 10 mM Na phosphate at pH 7.6 and determined the activation energy (enthalpy) of denaturation under these conditions, kcal/mol . Similar analysis at acidic pH was hampered by VLDL destabilization that led to rapid lipoprotein rupture and lipid phase separation, which manifested itself as a loss of spectroscopic signal at advanced stages of heat denaturation (grey lines in Figures 4(b) and 4(c)). This precluded accurate turbidity measurements necessary to determine the denaturation rate constants k(T) and thereby hampered quantitative analysis of VLDL stability at acidic pH. As a ballpark estimate of the pH-induced reduction in VLDL stability, we compared the T-jump data recorded at 80°C in 10 mM Na phosphate at pH 7.4 or pH 6.0. VLDL denaturation proceeds at least 20 times faster at pH 6.0 as compared to pH 7.4, ≥ 20. Therefore, the reduction in pH from 7.4 to 6.0 corresponds to a reduction in kinetic stability by kcal/moL.
Qualitatively, reduction in VLDL stability at acidic pH was confirmed by negative staining EM. Electron micrographs consistently showed that the heat-induced remodeling of VLDL proceeded via similar stages at different pH but occurred faster at acidic as compared to basic conditions. For example, at pH 6.2, VLDL heating at a rate of 11°C/h to 70°C led to substantial particle fusion (Figure 3(b)), yet similar heating at pH 7.6 caused no morphologic changes in VLDL. Further heating to 80°C led to formation of large lipid droplets and small HDL-size particles at pH 6.2 (Figure 3(c)), yet at pH 7.6 only fused particles were observed (similar to those in Figure 3(b)). Taken together, our EM, CD, and turbidity data recorded in the melting and kinetic experiments clearly showed that reduction in pH from mildly basic to mildly acidic accelerates heat-induced VLDL remodeling and, hence, destabilizes VLDL.
3.2. Effects of Salt
Effects of ionic strength on the structural stability of VLDL were first determined in dilute Na phosphate buffer at pH 7.6. At this pH and room temperature, changes in the salt concentration from 1 to 150 mM Na2HPO4 or from 0 to 100 mM NaCl or Na2SO4 produced no changes in VLDL morphology or in the protein conformation that could be detected by EM or by far- and near-UV CD, respectively. Furthermore, EM data showed that the products of the heat-induced structural transitions, including VLDL fusion, rupture and fission of small HDL-size particles, are similar under any solvent ionic conditions explored. However, CD and turbidity data recorded in the melting and kinetic experiments revealed large effects of salt on the temperature range and the rate of VLDL denaturation.
First, the melting data were recorded from VLDL solutions varying in Na phosphate concentration from 1 to 150 mM under otherwise identical conditions (0.1 mg/mL protein, pH 7.6). The samples were heated from 25 to 98°C at a rate of 11°C/h and CD, and turbidity melting data, Θ320(T) and V320(T), were recorded simultaneously at 320 nm. Selected data are presented in Figures 5(a) and 5(b). These and other data clearly show that increasing Na phosphate concentration from 1 to 25 mM progressively shifts VLDL fusion and rupture to lower temperatures by up to −10°C, indicating salt-induced reduction in stability. These low-temperature shifts were accompanied by a progressive increase in the amplitude and the apparent cooperativity of the transition (Figures 5(a) and 5(b)), suggesting formation of larger lipid droplets in higher-salt solutions; such large droplets were detected by electron microscopy at ≥25 mM Na phosphate (data not shown). Moreover, heat-induced VLDL rupture in solutions at ≥25 mM Na phosphate led to a rapid lipid phase separation that was visible by eye. This manifested itself as a signal loss, for example, reduction in CD amplitude following VLDL rupture at high temperatures (light grey line in Figure 5(b)), precluding accurate spectroscopic measurements in high-salt solutions at advanced stages of VLDL denaturation.
The apparent temperature Tm of the heat denaturation was determined from the peak position in the 1st derivative of the turbidity data, dV(T)/dT. These data were recorded in 1–100 mM Na phosphate at pH 7.6. Figure 5(c) shows Tm plotted as function of salt concentration. This plot illustrates a large reduction in Tm from 92 to 76°C upon increasing Na phosphate concentration from 1 to 100 mM. The dominant effect of salt at these concentrations is ionic screening. Furthermore, the plot of Tm versus salt concentration was well approximated by an exponential decay function (solid line in Figure 5(c)), which is characteristic of ionic screening by diffuse counterions [34, 35]. Thus, the results in Figure 5(c) suggest strongly that the salt-induced reduction in stability results from ionic screening of favorable electrostatic interactions on VLDL surface.
Next, we tested whether the salt-induced decrease in the water activity contributes to reduction in VLDL stability. The hydrophobic effect of salt on macromolecular stability usually becomes significant above 0.1 M salt [34, 35] and can be mimicked by nonionic compounds such as sugars. To test this effect, CD and turbidity melting data were recorded from VLDL solutions containing 0.1 mg/mL protein, 10 mM Na phosphate buffer at pH 7.6, and 0 or 10% sucrose. Such sucrose solution has the water activity similar to that of the physiological saline (~150 mM NaCl). The melting data recorded of VLDL in 0 and 10% sucrose under otherwise identical conditions fully overlapped (not shown). Therefore, at and below physiologic salt concentrations, salt-induced changes in the water activity caused no detectable changes in VLDL stability. Taken together, our results indicate that the reduction in VLDL stability upon increasing salt concentration results from ionic screening of favorable electrostatic interactions.
The effect of salt on VLDL stability was further explored in kinetic experiments. VLDL samples (0.1 mg/mL protein, pH 7.6) containing 5–25 mM Na phosphate were subjected to T-jumps from 25°C to 70–98°C. VLDL fusion and rupture were monitored by turbidity at 220 nm, V220 (t). Figure 6(a) illustrates selected T-jump data recorded at 85°C. Comparison of such data recorded at this and other temperatures clearly shows that addition of salt accelerates VLDL fusion and rupture and, hence, reduces VLDL stability. To quantify this effect, we used Arrhenius analysis. The V220 (t) data recorded in 5 to 25 mM Na2HPO4 were approximated by exponential decay functions, the unfolding rates k(T) were determined, and the Arrhenius plots, −RTln k(T) versus 1/T, were obtained. Monoexponential denaturation kinetic was observed at ≥20 mM salt, while at 2–10 mM salt two exponents were required to fit the V220 (t) data, suggesting two distinct kinetic phases in VLDL denaturation. A similar two-phase kinetics was observed in our earlier study of VLDL stability in 10 mM Na phosphate, pH 7.6 . In that study, CD, turbidity, and EM data showed that the 1st phase involves fusion of intact VLDL and fission of HDL-like particles and the 2nd phase involves lipoprotein rupture and release of apolar core lipids ; the Arrhenius plots for these two phases were parallel with a slope corresponding to the activation energy (enthalpy) kcal/mol. In the current study, we used the 1st kinetic phase (i.e., fusion of intact VLDL and fission of HDL-size particles) for comparison of the effect of salt on VLDL stability. The results showed that increasing Na phosphate concentration from 5 to 25 mM leads to a large decrease in the slope of the Arrhenius plot which corresponds to a decrease in the activation energy of VLDL denaturation, from kcal/mol in 5 mM Na2HPO4 to kcal/mol in 25 mM Na2HPO4 (Figure 5(c)). Linear extrapolation of the Arrhenius plots to 37°C suggests that increasing Na phosphate concentration from 5 to 25 mM leads to a reduction in kinetic stability by about δΔG* (37°C) = −3 ± 0.5 kcal/mol (Figure 6(b), double arrow). In summary, our CD, turbidity, and EM data recorded in the melting and kinetic experiments consistently show a large reduction in VLDL stability upon increasing Na phosphate concentration. The Arrhenius analysis demonstrates that this reduction in stability is enthalpy driven (Figure 6(b)). The latter is consistent with the enthalpy-driven ionic screening effect of salt (which is indicated by melting data in Figure 5(c)), as opposed to the entropy-driven salt effect on the water activity.
To assess the effects of other Na salts on thermal denaturation of VLDL, we used 10 mM NaCl or Na2SO4 in 5 mM Na phosphate buffer at pH 7.6. TRIS buffer could not be used in these studies because of its unfavorable interactions with lipoproteins and apolipoproteins (see Section 2 and Figure S1). Turbidity melting data recorded of VLDL at a heating rate of 11°C/h showed a large low-temperature shift by about −15°C in the presence of 10 mM NaCl and an even larger shift in 10 mM Na2SO4, indicating reduction in VLDL stability by these salts (Figure 7(a)). Furthermore, kinetic data recorded by turbidity in T-jumps to 85°C (Figure 7(b)) or other temperatures showed faster VLDL denaturation in 10 mM NaCl and, particularly, Na2SO4 as compared to buffer alone. Quantitative analyses of the T-jump data recorded in 0–10 mM NaCl or Na2SO4 were performed, and the Arrhenius plots were extrapolated to near-physiologic temperatures (solid lines in Figure 7(c)). The results showed that, at 37°C, VLDL stability changes by about δΔG* (37°C) = −2 kcal/mol in the presence of 10 mM NaCl and by about −2.5 kcal/moL in 10 mM Na2SO4 (double arrows in Figure 7(c)). A large enthalpic contribution to this reduction in stability is evident from the large differences in the slopes of the Arrhenius plots (Figure 7(c), black, gray, and light-gray lines), which correspond to activation energies kcal/mol in 5 mM Na phosphate buffer alone, kcal/mol in buffered 10 mM NaCl solution, and kcal/mol in buffered 10 mM Na2SO4 solution. These effects are comparable to the destabilizing effect of Na phosphate on VLDL (Figure 6). In summary, different Na salts have similar but not identical destabilizing effects on VLDL, suggesting the role of the anions in the electrostatic screening. These effects are enthalpy driven and result from ionic screening of favorable electrostatic interactions on VLDL surface.
4.1. Favorable Electrostatic Interactions Stabilize VLDL: Comparison with LDL and HDL
The results of our CD, turbidity, and EM studies revealed that increase in Na salt concentration from 10 to 100 mM and/or reduction in pH from 8.2 to 6.0 destabilize VLDL without changing the nature of their thermal remodeling (Figures 3–5). Arrhenius analysis of this remodeling shows that the salt-induced reduction in VLDL stability is an enthalpic effect (Figures 6 and 7). This is consistent with the ionic screening mechanism indicated by the dependence of the apparent melting temperature Tm on the salt concentration (Figure 5(c)); in fact, ionic screening of electrostatic interactions within the lipoprotein is expected and observed to reduce the enthalpy of lipoprotein remodeling. It is also consistent with the negligible effect of salt-induced changes in the water activity on VLDL stability evident from the absence of any effect of 10% glucose on VLDL stability. We conclude that electrostatic interactions help stabilize the VLDL assembly; hence, screening of these interactions by the salt ions reduces VLDL stability.
What groups form favorable electrostatic interactions in VLDL? Since most lipoprotein charges are located on the protein, the dominant effect is probably due to Coulombic protein-protein interactions, such as the putative salt bridge networks in class-A apolipoprotein α-helices . Even though surface salt bridges are not necessarily stabilizing, their optimized networks can confer high structural stability to proteins [36–38] and, potentially, to lipoproteins [23, 24]. In addition, interactions between phospholipid head groups and/or free fatty acids with the basic residues, which in class-A helices are located at the polar-apolar interface in close proximity to lipid [21, 22], may also be important. The role of class-A α-helices is further supported by the comparison of the ionic strength effects on the structural stability of various classes of human lipoproteins. VLDL and HDL show similar effects of salt and, hence, are stabilized by favorable electrostatic interactions . In contrast, LDL stability shows only a small change upon increasing salt concentration from 5 to 500 mM (Figure S2), suggesting that the net effect of the electrostatic interactions on LDL stability is much smaller than that in VLDL or HDL. As HDL contain only exchangeable apolipoproteins, LDL only the nonexchangeable apoB, and VLDL both exchangeable and nonexchangeable apolipoproteins, we speculate that the favorable electrostatic interactions observed in VLDL and HDL result, in part, from the abundance of the exchangeable apolipoproteins on the surface of these particles. High content of class-A α-helices in these proteins facilitates formation of extensive inter- and intrahelical salt bridge networks on the surface of HDL and VLDL. Conformational flexibility that is characteristic of the exchangeable apolipoproteins (reviewed in ) may help optimize the geometry of such salt bridge networks, while the low dielectric at the lipid-water interface is expected to amplify their effect on the lipoprotein stability.
4.2. Reduction in Stability at Mildly Acidic pH Is a Distinct Property of VLDL
VLDL is the only human lipoprotein that is destabilized upon lowering the pH from 8 to 6 (Figure 4). In contrast, the stability of human HDL and LDL does not significantly change in this pH range [24, 33]. To our knowledge, the only lipoproteins reported to have pH-dependent stability are binary complexes of human apoC-I, the smallest human apolipoprotein of 6 kD, with dipalmitoyl (16 0, 16 0) or distearoyl (18 0, 18 0) phosphatidylcholine . Such reconstituted lipoproteins contain approximately 15–20 protein molecules per particle. Similar to VLDL, the stability of these apoC-I-containing complexes decreases upon reduction in pH from 8 to 6, with the midpoint near pH 7.2 . In contrast, similar complexes containing apoA-I, the major HDL protein of 28 kD, show no pH effects on their stability . We proposed that these effects result, in part, from the titration of the N-terminal α-amino group. Numerous copies of such amino groups are present on particles containing apoC-I [14–19], as opposed to 2–4 copies of apoA-I per particle; hence, particles containing apoC-I but not apoA-I show large changes in their stability upon titration of these amino groups at near-neutral pH . Since each VLDL particle contains multiple copies of the exchangeable proteins on their surface (>20), we speculate that protonation of the N-terminal α-amino groups in these proteins contributes to the reduced VLDL stability at mildly acidic pH. Compared to VLDL, HDL and LDL contain some of the same proteins and lipids, yet they have only few protein molecules per particle (2–6) and, hence, only few -amino groups. This may explain why only VLDL, but not HDL or LDL, show significant pH-dependent changes in their stability at near-neutral pH. Titration of multiple His in apoB (that adopts different conformation on different-size particles, such as LDL and VLDL) and apoE may also contribute to the observed pH effects on VLDL stability. Furthermore, compared to HDL and LDL, VLDL have higher content of free fatty acids whose titration at near-neutral pH is also expected to contribute to the observed pH effect on VLDL stability.
4.3. Potential Physiologic Implications
Destabilization of VLDL upon transfer from mildly basic to mildly acidic conditions is particularly pronounced at pH < 6. In fact, at pH 5.7, VLDL disintegration was observed at ambient temperatures even in low-salt solutions (data not shown). This may have important physiologic implications, since such ionic conditions are encountered in vivo during VLDL remodeling and catabolism. One example is the degradation of VLDL and LDL via the whole-particle endocytosis, in which the lipoproteins are first transferred from plasma (pH 7.4) to early endosomes (pH = 5.5–6.0). In contrast to LDL that undergo lysosomal degradation, VLDL degradation starts in the low-salt mildly acidic endosomal environment and involves dissociation of the exchangeable apolipoproteins such as apoE together with some lipid; this process is essential for apoE recycling and biogenesis of an important apoE-containing HDL fraction [10–12]. The remaining apoB-containing particles undergo lysosomal degradation. Reduction in VLDL stability upon reduction in pH from 7.4 to 6 reported here is expected to facilitate their endosomal degradation, specifically, the dissociation of the apoE-containing fraction from the apoB-containing particle (Figure 1).
Another context in which a reduction in pH below neutrality may promote VLDL disintegration is atherosclerotic plaques. According to the widely accepted “response to retention hypothesis” of atherosclerosis ([14–16] and references therein), retention of LDL and VLDL in the arterial wall leads to their fusion and coalescence into small lipid droplets which are digested by macrophages; this triggers a cascade of proatherogenic and proinflammatory responses and culminates in the formation of foam cells and early atherosclerotic plaques. Such plaques contain lipoprotein-derived lipid droplets similar to those formed upon the heat-induced VLDL rupture (Figure 3(c)) [17, 18]. The near-neutral extracellular pH in early plaques becomes progressively acidic in more advanced plaques ( and references therein). We propose that such acidic environment destabilizes VLDL, enhancing their fusion and coalescence into large lipid droplets, such as the droplets found in the advanced atherosclerotic plaques.
Furthermore, potential use of lipoproteins as carriers of lipophilic drugs depends critically on the structural stability of the carrier in plasma and in the target cells, particularly, its pH sensitivity [41, 42]. Our stability studies of plasma lipoproteins at pH 7.6 suggest that the lipoprotein stability tends to decrease with increasing particle size, from HDL to LDL to VLDL [20, 24, 33, 43]. Additional reduction in stability of larger particles such as VLDL at mildly acidic pH is one of the many factors to be considered when choosing a lipoprotein-based carrier for delivery of diagnostic or therapeutic agents to specific targets, such as the acidic microenvironment of solid tumors .
|VLDL:||Very low-density lipoprotein|
The authors thank Cheryl England and Michael Gigliotti for lipoprotein isolation and Donald L. Gantz for expert help with electron microscopy. They are grateful to Dr. Shobini Jayaraman for many useful discussions and for providing the data illustrating the effect of salt on thermal stability of human LDL (supplemental Figure S2). They also thank the reviewers for their helpful comments. This work was supported by the National Institutes of Health Grants GM067260 and HL026355.
The supplementary material includes the melting data illustrating the destabilizing effects of TRIS on VLDL assembly and the effect of salt on LDL stability.
- R. M. Krauss, “Atherogenicity of triglyceride-rich lipoproteins,” American Journal of Cardiology, vol. 81, no. 4 A, pp. 13B–17B, 1998.
- M. Adiels, S. O. Olofsson, M. R. Taskinen, and J. Borén, “Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 28, no. 7, pp. 1225–1236, 2008.
- P. Therond, “Catabolism of lipoproteins and metabolic syndrome,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 12, no. 4, pp. 366–371, 2009.
- R. J. Havel, “Triglyceride-rich lipoproteins and plasma lipid transport,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 1, pp. 9–19, 2010.
- W. B. Kannel and R. S. Vasan, “Triglycerides as vascular risk factors: new epidemiologic insights,” Current Opinion in Cardiology, vol. 24, no. 4, pp. 345–350, 2009.
- G. M. Dallinga-Thie, R. Franssen, H. L. Mooij et al., “The metabolism of triglyceride-rich lipoproteins revisited: new players, new insight,” Atherosclerosis, vol. 211, no. 1, pp. 1–8, 2010.
- W. C. Breckenridge, “The catabolism of very low density lipoproteins,” Canadian Journal of Biochemistry and Cell Biology, vol. 63, no. 8, pp. 890–897, 1985.
- T. A. Musliner, M. D. Long, T. M. Forte et al., “Dissociation of high density lipoprotein precursors from apolipoprotein B-containing lipoproteins in the presence of unesterified fatty acids and a source of apolipoprotein A-I,” Journal of Lipid Research, vol. 32, no. 6, pp. 917–933, 1991.
- L. Krimbou, M. Marcil, H. Chiba, and J. Genes, “Structural and functional properties of human plasma high density-sized lipoprotein containing only apoE particles,” Journal of Lipid Research, vol. 44, no. 5, pp. 884–892, 2003.
- P. C. N. Rensen, M. C. Jong, L. C. Van Vark et al., “Apolipoprotein E is resistant to intracellular degradation in vitro and in vivo. Evidence for retroendocytosis,” Journal of Biological Chemistry, vol. 275, no. 12, pp. 8564–8571, 2000.
- J. Heeren and U. Beisiegel, “Intracellular metabolism of triglyceride-rich lipoproteins,” Current Opinion in Lipidology, vol. 12, no. 3, pp. 255–260, 2001.
- J. Heeren, U. Beisiegel, and T. Grewal, “Apolipoprotein E recycling: implications for dyslipidemia and atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 3, pp. 442–448, 2006.
- V. Anber, J. S. Millar, M. McConnell, J. Shepherd, and C. J. Packard, “Interaction of very-low-density, intermediate-density, and low-density lipoproteins with human arterial wall proteoglycans,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 17, no. 11, pp. 2507–2514, 1997.
- G. Camejo, E. Hurt-Camejo, O. Wiklund, and G. Bondjers, “Association of apo B lipoproteins with arterial proteoglycans: pathological significance and molecular basis,” Atherosclerosis, vol. 139, no. 2, pp. 205–222, 1998.
- K. Skålén, M. Gustafsson, E. Knutsen Rydberg et al., “Subendothelial retention of atherogenic lipoproteins in early atherosclerosis,” Nature, vol. 417, no. 6890, pp. 750–754, 2002.
- I. Tabas, K. J. Williams, and J. Borén, “Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications,” Circulation, vol. 116, no. 16, pp. 1832–1844, 2007.
- J. R. Guyton and K. F. Klemp, “Development of the atherosclerotic core region: chemical and ultrastructural analysis of microdissected atherosclerotic lesions from human aorta,” Arteriosclerosis and Thrombosis, vol. 14, no. 8, pp. 1305–1314, 1994.
- Byung Hong Chung, G. Tallis, V. Yalamoori, G. M. Anantharamaiah, and J. P. Segrest, “Liposome-like particles isolated from human atherosclerotic plaques are structurally and compositionally similar to surface remnants of triglyceride- rich lipoproteins,” Arteriosclerosis and Thrombosis, vol. 14, no. 4, pp. 622–635, 1994.
- K. Oorni, M. O. Pentikainen, M. Ala-Korpela, and P. T. Kovanen, “Aggregation, fusion, and vesicle formation of modified low density lipoprotein particles: molecular mechanisms and effects on matrix interactions,” Journal of Lipid Research, vol. 41, no. 11, pp. 1703–1714, 2000.
- M. Guha, C. England, H. Herscovitz, and O. Gursky, “Thermal transitions in human very-low-density lipoprotein: fusion, rupture, and dissociation of HDL-like particles,” Biochemistry, vol. 46, no. 20, pp. 6043–6049, 2007.
- J. P. Segrest, M. K. Jones, H. De Loof, C. G. Brouillette, Y. V. Venkatachalapathi, and G. M. Anantharamaiah, “The amphipathic helix in the exchangeable apolipoproteins: a review of secondary structure and function,” Journal of Lipid Research, vol. 33, no. 2, pp. 141–166, 1992.
- J. P. Segrest, M. K. Jones, A. E. Klon et al., “A detailed molecular belt model for apolipoprotein A-I in discoidal high density lipoprotein,” Journal of Biological Chemistry, vol. 274, no. 45, pp. 31755–31758, 1999.
- S. Benjwal, S. Jayaraman, and O. Gursky, “Electrostatic effects on the stability of discoidal high-density lipoproteins,” Biochemistry, vol. 44, no. 30, pp. 10218–10226, 2005.
- S. Jayaraman, D. L. Gantz, and O. Gursky, “Effects of salt on the thermal stability of human plasma high-density lipoprotein,” Biochemistry, vol. 45, no. 14, pp. 4620–4628, 2006.
- I. N. Gorshkova, T. Liu, H.-Y. Kan, A. Chroni, V. I. Zannis, and D. Atkinson, “Structure and stability of apolipoprotein A-I in solution and in discoidal high-density lipoprotein probed by double charge ablation and deletion mutation,” Biochemistry, vol. 45, no. 4, pp. 1242–1254, 2006.
- R. Raffaï, K. H. Weisgraber, R. MacKenzie et al., “Binding of an antibody mimetic of the human low density lipoprotein receptor to apolipoprotein E is governed through electrostatic forces. Studies using site-directed mutagenesis and molecular modeling,” Journal of Biological Chemistry, vol. 275, no. 10, pp. 7109–7116, 2000.
- H. Saito, P. Dhanasekaran, D. Nguyen et al., “Characterization of the heparin binding sites in human apolipoprotein E,” Journal of Biological Chemistry, vol. 278, no. 17, pp. 14782–14787, 2003.
- J. G. Boucher, T. Nguyen, and D. L. Sparks, “Lipoprotein electrostatic properties regulate hepatic lipase association and activity,” Biochemistry and Cell Biology, vol. 85, no. 6, pp. 696–708, 2007.
- D. L. Sparks, C. Chatterjee, E. Young, J. Renwick, and N. R. Pandey, “Lipoprotein charge and vascular lipid metabolism,” Chemistry and Physics of Lipids, vol. 154, no. 1, pp. 1–6, 2008.
- M. Lee-Rueckert, J. Lappalainen, H. Leinonen, T. Pihlajamaa, M. Jauhiainen, and P. T. Kovanen, “Acidic extracellular environments strongly impair ABCA1-mediated cholesterol efflux from human macrophage foam cells,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 30, no. 9, pp. 1766–1772, 2010.
- V. N. Schumaker and D. L. Puppione, “Sequential flotation ultracentrifugation,” Methods in Enzymology, vol. 128, pp. 155–170, 1986.
- S. Benjwal, S. Verma, K. H. Röhm, and O. Gursky, “Monitoring protein aggregation during thermal unfolding in circular dichroism experiments,” Protein Science, vol. 15, no. 3, pp. 635–639, 2006.
- S. Jayaraman, D. Gantz, and O. Gursky, “Structural basis for thermal stability of human low-density lipoprotein,” Biochemistry, vol. 44, no. 10, pp. 3965–3971, 2005.
- R. Perez-Jimenez, R. Godoy-Ruiz, B. Ibarra-Molero, and J. M. Sanchez-Ruiz, “The efficiency of different salts to screen charge interactions in proteins: a Hofmeister effect?” Biophysical Journal, vol. 86, no. 4, pp. 2414–2429, 2004.
- B. N. Dominy, D. Perl, F. X. Schmid, and C. L. Brooks, “The effects of ionic strength on protein stability: the cold shock protein family,” Journal of Molecular Biology, vol. 319, no. 2, pp. 541–554, 2002.
- S. Kumar and R. Nussinov, “Relationship between ion pair geometries and electrostatic strengths in proteins,” Biophysical Journal, vol. 83, no. 3, pp. 1595–1612, 2002.
- G. I. Makhatadze, V. V. Loladze, D. N. Ermolenko, X. Chen, and S. T. Thomas, “Contribution of surface salt bridges to protein stability: guidelines for protein engineering,” Journal of Molecular Biology, vol. 327, no. 5, pp. 1135–1148, 2003.
- B. N. Dominy, H. Minoux, and C. L. Brooks, “An electrostatic basis for the stability of thermophilic proteins,” Proteins, vol. 57, no. 1, pp. 128–141, 2004.
- P. Linsel-Nitschke and A. R. Tall, “HDL as a target in the treatment of atherosclerotic cardiovascular disease,” Nature Reviews Drug Discovery, vol. 4, no. 3, pp. 193–205, 2005.
- M. Guha, D. L. Gantz, and O. Gursky, “Effect of fatty acyl chain length, unsaturation and pH on the stability of discoidal high-density lipoproteins,” Journal of Lipid Research, vol. 49, no. 8, pp. 1752–1761, 2008.
- M. Hammel, P. Laggner, and R. Prassl, “Structural characterisation of nucleoside loaded low density lipoprotein as a main criterion for the applicability as drug delivery system,” Chemistry and Physics of Lipids, vol. 123, no. 2, pp. 193–207, 2003.
- B. C. Ponnappa and Y. Israel, “Targeting Kupffer cells with antisense oligonucleotides,” Front Biosci, vol. 7, pp. e223–e233, 2002.
- X. Gao, S. Yuan, S. Jayaraman, and O. Gursky, “Differential stability of high-density lipoprotein subclasses: Effects of particle size and protein composition,” Journal of Molecular Biology, vol. 387, no. 3, pp. 628–638, 2009.
- S. K. Parks, J. Chiche, and J. Pouyssegur, “pH control mechanisms of tumor survival and growth,” Journal of Cellular Physiology, vol. 226, no. 2, pp. 299–308, 2011.
Copyright © 2011 Madhumita Guha and Olga Gursky. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.